Product Information
CEFDINIR 300 MG CAPSULE is a generic product labeled by BluePoint Laboratories, priced at $0.4581 per EA under NDC 68001036206. Its NADAC has been published 391 times since Jan 2, 2019.
Strength
300 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001036206
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA065434On Market Since
8/1/2018
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 300 MG CAPSULE has been published 391 times since Jan 2, 2019, and over the history we have for it it has declined 9.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4581 per EA |
|---|---|
| All-time high | $0.6042 (Jun 10, 2020) |
| All-time low | $0.3507 (Nov 20, 2024) |
| 52-week high | $0.4752 |
| 52-week low | $0.4551 |
| Median price | $0.4714 |
| Average price | $0.4768 |
| Largest weekly change | -25.5% (Nov 20, 2024) |
| Weeks tracked | 391 |
| Tracking since | Jan 2, 2019 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFDINIR 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 300 MG CAPSULE, manufactured by BluePoint Laboratories, is $0.4581 per EA (NDC 68001036206), effective Jun 24, 2026.
How has the price of CEFDINIR 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFDINIR 300 MG CAPSULE has declined 9.6%. It has been tracked across 391 weekly CMS publications since Jan 2, 2019.
What are the highest and lowest recorded NADAC prices for CEFDINIR 300 MG CAPSULE?
Since Jan 2, 2019, the NADAC for CEFDINIR 300 MG CAPSULE has ranged from a low of $0.3507 (Nov 20, 2024) to a high of $0.6042 (Jun 10, 2020), with a median of $0.4714 per EA.
Are there cheaper alternatives to CEFDINIR 300 MG CAPSULE?
7 NADAC-published products share the same active ingredient, strength, and dosage form as CEFDINIR 300 MG CAPSULE, but none are currently priced below it.
Who manufactures CEFDINIR 300 MG CAPSULE?
CEFDINIR 300 MG CAPSULE (NDC 68001036206) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification